The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial and pharmacokinetic study of Tanibirumab, a fully human monoclonal antibody to the vascular endothelial growth factor receptor 2 in patients with refractory solid tumors.
 
Su Jin Lee
No Relationships to Disclose
 
Jun Soo Ham
No Relationships to Disclose
 
Hee Kyung Kim
No Relationships to Disclose
 
Seonggyu Byeon
No Relationships to Disclose
 
Seon Young Lee
Employment - PharmABcine
 
Weon Sup Lee
Employment - PharmABcine
 
Jin San Yoo
Leadership - PharmABcine
 
Jong Mu Sun
No Relationships to Disclose
 
Jeeyun Lee
No Relationships to Disclose
 
Se Hoon Park
No Relationships to Disclose
 
Joon Oh Park
No Relationships to Disclose
 
Myung-Ju Ahn
No Relationships to Disclose
 
Ho Yeong Lim
No Relationships to Disclose
 
Won Ki Kang
No Relationships to Disclose
 
Young Suk Park
No Relationships to Disclose